TMC the metals company $TMC is an exploration and development enterprise targeting the collection of seafloor polymetallic nodules in the Clarion-Clipperton Zone to supply critical energy transition metals. The company controls estimated resources of over 1.6 billion tonnes grading above seven percent copper-equivalent, underpinning projected bottom-quartile production costs for nickel, copper, cobalt, and manganese. With a strategic pivot to a capital-light collection model and an initial toll-processing partnership in Japan, shares currently trade at a substantial discount to the estimated 23 billion dollar portfolio net present value. As Western manufacturers seek low-carbon battery materials, can this ocean developer secure key regulatory approvals from NOAA and the International Seabed Authority to unlock its massive commercial potential?
112
The AES Corporation $AES is a global power provider operating regulated electric utilities alongside an expansive wholesale clean energy generation platform. With deep expertise in utility-scale solar, wind, and battery storage, the company has become a premier supplier of round-the-clock clean electricity to tech hyperscalers building artificial intelligence data centers. Despite maintaining an 11.1 gigawatt project backlog and consistent rate base expansion, heavy balance sheet leverage pressured public market performance. In response, the firm agreed to a 33.4 billion dollar all-cash take-private acquisition by Global Infrastructure Partners and EQT Infrastructure at a valuation of 15.00 dollars per share. Can private ownership provide the capital flexibility needed to dominate the next era of clean power and computing infrastructure?
150
Anthropic $ANT has established a commanding position in enterprise artificial intelligence, capturing an estimated 54% market share in software coding automation through its flagship Claude model family. The company demonstrated unprecedented top-line momentum by scaling annualized run-rate revenue to approximately $81 billion following its historic public debut. Substantial liquidity exceeding $130 billion provides formidable capital strength to support long-term expansion across automated enterprise workflows and autonomous agent architectures. Can the company maintain its explosive growth trajectory and justify its premium valuation multiple while managing over $900 billion in committed compute obligations?
2
173
Diodes Incorporated $DIOD is a global semiconductor manufacturer delivering essential analog, discrete, and mixed-signal chips across automotive, industrial, and computing markets. The company is capitalizing on powerful secular tailwinds in electric vehicles and artificial intelligence server hardware, expanding silicon content per platform while driving shipments to an annual run-rate of sixty billion units. Supported by record quarterly revenues and a robust balance sheet with over one hundred million dollars in net cash, consensus analyst price targets point toward significant valuation upside compared to current trading levels. Can Diodes leverage its cost-advantaged hybrid manufacturing model to outpace major analog competitors and reach the long-term management target of two point five billion dollars in annual revenue?
112
Xencor $XNCR is a clinical-stage biopharmaceutical pioneer operating an innovative dual-engine model that pairs internal oncology drug development with high-margin platform licensing partnerships. Its proprietary XmAb technology platform powers over twenty-five clinical programs across industry leaders like AstraZeneca and Astellas, generating recurring milestone and royalty streams. With over 555 million dollars in cash and zero debt, the company boasts a robust operational runway into 2029 to advance its promising solid tumor bispecific candidates, led by XmAb819 for renal cell carcinoma. Currently trading at an enterprise value of approximately 2.03 billion dollars, the company offers an asymmetric risk-reward profile anchored by steady royalty floors and pivotal clinical catalysts approaching in 2027. Will the clinical momentum of XmAb819 propel the company into commercial independence before its foundational partner royalties face patent expiration in 2028?
1
138
Hormel Foods Corporation $HRL operates a resilient branded food portfolio anchored by category staples such as SPAM, Skippy, and Planters. While retail grocery volumes have faced pressure from cautious consumer spending, the company continues to generate steady organic growth across its commercial foodservice division. Trading at roughly 14 times forward adjusted earnings alongside a dividend yield exceeding 5%, the equity trades at a notable discount to historical valuation averages. Future business prospects will largely depend on successfully integrating value-added acquisitions like Brakebush Brothers and capturing operating efficiencies through enterprise modernization initiatives. Can strategic portfolio reshaping and consistent cash generation enable this legacy food giant to deliver durable upside from its discounted valuation?
166
Canton Strategic Holdings $CNTN operates as an institutional digital asset infrastructure provider and authorized Super Validator for the privacy-enabled Canton Network. The company demonstrated rapid operational momentum in the third quarter of 2026, generating 104% sequential revenue growth to 3.05 million dollars and achieving its first-ever positive quarterly Adjusted EBITDA. Backed by 3.83 billion Canton Coins and substantial cash reserves that bring total balance sheet net asset value to over 509 million dollars, the stock trades at an attractive 25% to 73% discount to its underlying liquid assets. As the firm prepares to unlock additional validator weight allocations through 2028 and scale institutional tokenization, will the market re-rate the equity to bridge this massive valuation gap?
252
Uniti Group Inc $UNIT operates an expansive communications infrastructure footprint spanning approximately 240,000 route miles of fiber across secondary and tertiary American markets. Following its transformative merger with Windstream, the company is capturing strong tailwinds from the artificial intelligence boom through surging hyperscaler demand for dark fiber and high-capacity optical wave transport. However, its aggressive fiber-to-the-home expansion to reach 3.5 million homes must overcome significant balance sheet pressure from an eleven billion dollar net debt burden and ongoing legacy copper customer churn. Can this highly leveraged telecom turnaround successfully execute its network conversion to unlock substantial equity value, or will mounting debt service obligations overwhelm future growth?
275
StoneCo $STNE powers over 5.1 million Brazilian merchants through its integrated payment processing, digital banking, and proprietary Stone Hub distribution network. Trading at an ultra-depressed valuation of just 3 to 4 times trailing earnings with net cash on the balance sheet, the equity reflects severe margin pressure from elevated Brazilian interest rates and rising credit provisions. However, the company continues to generate a robust 23.5 percent return on equity while aggressively repurchasing shares and pivoting its loan book toward government-guaranteed credit to mitigate risk. As monetary policy eventually eases and digital banking adoption deepens across Brazil, the business model provides substantial operating leverage for a cyclical recovery. Will management successfully stabilize credit quality and reignite profit margins to deliver asymmetric upside for patient investors, or will macroeconomic headwinds keep the multiple permanently discounted?
1
234
Figure Technology Solutions $FIGR operates a high-growth capital marketplace transforming consumer lending and digital asset infrastructure through enterprise blockchain deployment. By replacing manual underwriting with automated valuation models on the Provenance Blockchain, the platform funds home equity lines of credit in days rather than weeks while slashing operational processing costs to just 67 basis points of loan volume. Third-quarter performance underscored accelerating momentum as loan marketplace volume surged 135 percent year over year to 5.8 billion dollars, backed by 1.6 billion dollars in cash reserves and an expanded 400 million dollar share repurchase authorization. As the company scales its capital-light marketplace and expands into commercial investor financing, will Wall Street continue to reprice Figure as a premier financial technology platform rather than a cyclical mortgage lender?
Evergy $EVRG operates as a rate-regulated electric utility serving approximately 1.7 million customers across eastern Kansas and western Missouri. The company is committing 21.6 billion dollars to an expansive five-year capital investment program designed to drive an 11.5 percent compound annual rate base growth rate through 2030. Long-term business prospects are strongly supported by a 2.5 to 3.0 gigawatt pipeline of hyperscale data center commitments that management expects will lift annual adjusted earnings per share growth above eight percent starting in 2028. Supported by a forward dividend yield of 3.27 percent and valuations near historical sector norms, the company presents a compelling risk-reward profile anchored by predictable regulatory cash flows. Can Evergy execute its massive infrastructure buildout and maintain regulatory stability while powering the Midwest tech expansion?
191
iShares Semiconductor ETF $SOXX tracks the NYSE Semiconductor Index to provide balanced exposure across industry-leading chip designers, device manufacturers, and capital equipment producers. The portfolio trades at a prospective price-to-earnings ratio of 19.97x while its underlying constituent holdings generate an exceptional average net profit margin of 31.43%. Long-term business prospects remain anchored by accelerating artificial intelligence infrastructure spending and an expanding global semiconductor market projected to surpass one trillion dollars by 2030. With five-year scenario models establishing a probability-weighted price target of $323.35, can this structural hardware expansion withstand potential geopolitical supply chain disruptions in the Taiwan Strait?
187
Harrow $HROW is a commercial-stage specialty pharmaceutical leader that has successfully transitioned from generic compounding into high-margin branded ophthalmic therapeutics. The enterprise is experiencing robust top-line momentum driven by surging clinical adoption of its flagship dry eye disease treatments VEVYE and TYRVAYA alongside surgical assets like IHEEZO. Wall Street maintains a unanimous buy consensus with valuation multiples hovering near three and a half times forward sales, even as the company balances three hundred million dollars in senior debt. Can Harrow successfully expand commercial payor access and accelerate cash flow to service its obligations while realizing its ambitious long-term market potential?
293
Energy Fuels $UUUU is transitioning from a domestic uranium producer into an integrated Western critical minerals powerhouse. Anchored by the irreplaceable White Mesa Mill in Utah, the company holds over 900 million dollars in liquid net assets that back nearly half of its current market capitalization. Strategic expansion into rare earth element processing and downstream magnet manufacturing positions the business to capture high-margin upside as clean energy demand accelerates. With solid balance sheet liquidity and strong secular tailwinds, could this critical minerals supplier offer significant long-term upside for investors?
LivaNova PLC $LIVN delivers specialized medical technology through its core cardiopulmonary and neuromodulation business segments. The company recently reported strong third-quarter financial results with net revenue growing ten percent year-over-year to over 393 million dollars, prompting executive management to raise full-year revenue and earnings guidance. Commercial growth is underpinned by the capital replacement cycle of its flagship Essenz perfusion system alongside therapeutic expansion into obstructive sleep apnea and drug-resistant depression. With the stock trading at a forward earnings multiple below higher-growth medtech peers and Wall Street price targets reaching up to 120 dollars, can LivaNova sustain its momentum and capture significant upside in these expanding therapeutic markets?
200
NVIDIA Corporation $NVDA operates as the foundational hardware and software infrastructure engine driving the global shift toward accelerated computing and generative artificial intelligence. The company dominates the industry with an estimated 85% to 90% market share in AI processors, generating roughly 92.5% of its total revenue from its Data Center segment. Management projects revenue growth of approximately 70% for fiscal year 2028, bolstered by expanding rack-scale architectures and a massive multi-hundred-billion-dollar addressable market. Even with high switching costs fortified by over 6 million developers using its proprietary software platform, the business faces evolving dynamics from cloud custom silicon and high-bandwidth memory costs. Will its vertical integration and software ecosystem enable the semiconductor giant to sustain its long-term market leadership as global AI infrastructure scales?
1
217
In contrast, our best performer, Long Term Compounders is up 8% while the major indices are deep in the red.
90
Do you think AI will beat the pros? At Flash we do! In June we launched 3 new strategies designed to find the best ideas across thousands of companies. Our worst performer so far is our "Dividend Hunter" which is only up 4.4%
1
212
Hyperliquid Strategies Inc. $PURR operates as a premier digital asset treasury company providing investors with regulated equity exposure to the Hyperliquid blockchain. The firm generates steady operational cash flow from validator node staking while capturing protocol value driven by Hyperliquid's massive programmatic fee-burn mechanism. Supported by a zero-debt balance sheet and substantial cash reserves, the company recently reported 620.6 million dollars in quarterly net income as its HYPE token treasury expanded. Management actively optimizes shareholder value by issuing equity at a premium to net asset value and executing stock buybacks whenever the shares trade at a discount. Do you think Hyperliquid Strategies offers a compelling structural bridge for institutional capital seeking productive crypto exposure?



















